Obesity significantly impairs female reproductive outcomes through mechanisms including anovulation, reduced implantation, and increased miscarriage risk. Glucagon-like peptide-1 receptor agonist (GLP-1 RAs), particularly semaglutide (Ozempic), demonstrate robust weight reduction efficacy and potential reproductive benefits in women with obesity and polycystic ovary syndrome (PCOS). Emerging evidence suggests improvements in menstrual cyclicity, oocyte quality, and spontaneous conception rates, mediated by both metabolic and weight loss-independent mechanisms such as reduced inflammation and androgen levels. Clinical data from randomized controlled trials and observational cohorts provide preliminary reassurance that inadvertent first-trimester exposure to semaglutide does not increase major congenital malformation risk, though concerns from animal studies necessitate cautious use. Regulatory authorities recommend discontinuation of semaglutide at least two months prior to conception, emphasizing preconception counseling and reliable contraception. Compared to other anti-obesity pharmacotherapies, GLP-1 RAs show a more favorable reproductive safety profile. However, substantial knowledge gaps remain regarding long-term reproductive outcomes, live birth rates, and offspring development, warranting further prospective studies and pregnancy registry data. This review synthesizes current medical evidence on the “Ozempic pregnancy phenomenon,” offering clinical guidance for reproductive-aged women prescribed semaglutide and highlighting priorities for future research in reproductive endocrinology.
1 September 2025 in Clinical Medicine And Health Research Journal
This study examines the medical practices documented in biblical texts, focusing on their historical significance and potential modern applications. Through systematic analysis of ancient Hebrew and Greek manuscripts, along with archaeological evidence, we investigated the therapeutic approaches described in both Old and New Testaments. The research methodology combined textual analysis of original sources with comparative studies of contemporary Middle Eastern medical practices from 2000 BCE to 100 CE. Our findings reveal that biblical medical treatments often integrated physical remedies with spiritual practices, including the use of plant-based medicines, dietary laws, and quarantine procedures that demonstrated remarkable alignment with basic principles of modern hygiene and public health. This research contributes to our understanding of ancient medical knowledge and suggests that some biblical medical practices were grounded in empirical observations that maintain relevance in contemporary healthcare discussions. These findings provide valuable insights into the historical development of medical practices and the intersection of spiritual and physical healing in ancient Near Eastern cultures.
1 September 2025 in Clinical Medicine And Health Research Journal
The medical community has long linked microaneurysm rupture risk to size. Larger bulges were thought to be more dangerous. But recent clinical findings have turned this conventional wisdom on its head. Even the smallest aneurysms can seriously threaten brain health. Studies now show that tiny aneurysms (≤3 mm) cause much of the subarachnoid hemorrhage cases. This discovery challenges risk assessment protocols that doctors have used for decades. These small vascular abnormalities can show no warning signs before a catastrophic rupture. Scientists understand a lot about macroaneurysm rupture. The mechanisms behind small aneurysm failures remain nowhere near as clear. The anterior communicating artery (AComA) seems to increase rupture risk whatever the size. Research continues on whether fusiform aneurysms follow this same pattern. Medical teams still debate the best way to manage these dangerous vascular anomalies. This piece dives into fresh evidence that challenges size-based risk models for brain aneurysms. We'll learn about the surprising relationship between aneurysm size and rupture risk. The text explores location-specific vulnerability patterns and reviews current treatment approaches for these overlooked vascular threats. Doctors need this knowledge to make intervention decisions. Patients need it to weigh treatment options against the risk of catastrophic bleeding.
10 May 2025 in Journal of Education, Health and Sport
The aim of this article is to analyze the issue of obesity during pregnancy as a significant health challenge for both the mother and the developing fetus. Maternal obesity is associated with numerous health complications, including gestational diabetes and an increased risk of delivery interventions. The paper emphasizes the importance of proper diagnostics, nutritional education, and treatment in the care process for obese pregnant women. Current guidelines regarding weight gain during pregnancy and the role of an interdisciplinary team in minimizing the risk of complications are also discussed. An analysis of available studies and literature allows for a multifaceted approach to this issue.
Background/Objectives: The PHASES score is widely used to estimate the 5-year rupture risk of unruptured intracranial aneurysms, yet many patients present with aneurysmal subarachnoid haemorrhage despite low calculated risk. This study aimed to characterise the demographic and aneurysm-related profile of patients with ruptured aneurysms classified as low risk by PHASES. Methods: This retrospective single-centre observational study included 243 consecutive patients with radiologically confirmed ruptured intracranial aneurysms treated between 2013 and 2021. PHASES scores and estimated 5-year rupture risks were calculated retrospectively. Age, sex, arterial hypertension, aneurysm size, location, and multiplicity were analysed using non-parametric statistical methods. Results: The mean PHASES score was 5.16 ± 3.43 points. An estimated 5-year rupture risk below 1% was assigned to 125 patients (51.44%), and 54 patients (22.22%) had PHASES scores of 0–2. Ruptured aneurysms measuring ≤7 mm occurred in 147 patients (60.49%), and 210 patients (86.42%) were younger than 70 years. Internal carotid artery aneurysms were the most frequent overall, whereas anterior communicating artery aneurysms had the smallest median diameter while remaining among the most common rupture sites. Arterial hypertension was associated with larger aneurysm diameter. Conclusions: Low PHASES-estimated risks were common in this cohort of patients presenting with aneurysm rupture. Because the study included no comparison group with unruptured aneurysms, it cannot assess PHASES calibration or predictive performance. PHASES should therefore be used as a population-based decision-support tool rather than a stand-alone predictor of individual rupture risk, with morphology, imaging findings, documented growth, and patient-specific factors incorporated into clinical assessment.
20 May 2026 in European Journal of Translational and Clinical Medicine
Endoscopic spine surgery: methodology and outcomes based on patient feedback. Background: Endoscopic lumbar decompression (ELD) is emerging as a minimally invasive alternative to traditional microdiscectomy, potentially offer...